Chunyan Wu - Concepedia

Author

Chunyan Wu

Shanghai Pulmonary Hospital ORCID

Also Known As

C Y Wu, C. Wu, Chaoqin Wu, Chien-hui M. Wu, Chun-Yan Wu, Chun-yan Wu, Chunyan Wu, Chun‑Yan Wu, Wu, Chunyan, Yuming Zhu

114

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Shanghai Pulmonary Hospital Tongji University Shanghai Tenth People's Hospital University of Iowa Fudan University

About

Chunyan Wu is an author at Shanghai Pulmonary Hospital specializing in lung cancer, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	902
2	Cell Biology	10	10	426
3	Immunology	6	6	262
4	Engineering	2	2	70
5	Health Sciences	2	2	34

Chunyan Wu

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer Fengying Wu, Jue Fan, Yayi He, Nature Communications	2021	759
LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes Yayi He, Hui Yu, Leslie Rozeboom, Journal of Thoracic Oncology	2017	269
Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer Jian Chen, Yun Tan, Fenghuan Sun, Genome biology	2020	231
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies Qian Liu, Jing Zhang, Chenchen Guo, Cell Tumor BiologyMedicineBiological InsightsCancer GenomicsBronchial Neoplasm	2024	148
High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules Chunyan Wu, Chao Zhao, Yang Yang, Journal of Thoracic Oncology Somatic VariantDriver MutationsAdvanced Lung DiseaseMultiple Pulmonary NodulePathology	2015	142
Intratumoral Heterogeneity of <i>ALK</i>-Rearranged and <i>ALK</i>/<i>EGFR</i> Coaltered Lung Adenocarcinoma Weijing Cai, Dongmei Lin, Chunyan Wu, Journal of Clinical Oncology	2015	130
EGFR G796D mutation mediates resistance to osimertinib Di Zheng, Min Hu, Yu Bai, Oncotarget	2017	104
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma Tao Jiang, Jinpeng Shi, Zhengwei Dong, Journal of Hematology & Oncology	2019	104
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer Yilv Yan, Dongqing Sun, Junjie Hu, Nature Genetics Cancer ImmunosurveillanceNon-small-cell Lung CancerMedicineImmunologyCancer Genomics	2024	89
Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer Terry L. Ng, Yiwei Liu, Anastasios Dimou, Cancer	2018	79

Page 1